Exelixis
EXEL
#1726
Rank
C$16.99 B
Marketcap
C$63.12
Share price
0.46%
Change (1 day)
18.23%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company